- Home
- AARD vs GENC Comparison
AARD vs GENC Comparison
Compare AARD & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- GENC
- Stock Information
- Founded
- AARD 2017
- GENC 1894
- Country
- AARD United States
- GENC United States
- Employees
- AARD N/A
- GENC N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- GENC Construction/Ag Equipment/Trucks
- Sector
- AARD Health Care
- GENC Industrials
- Exchange
- AARD Nasdaq
- GENC Nasdaq
- Market Cap
- AARD 216.6M
- GENC 181.9M
- IPO Year
- AARD 2025
- GENC N/A
- Fundamental
- Price
- AARD $7.74
- GENC $12.53
- Analyst Decision
- AARD Strong Buy
- GENC
- Analyst Count
- AARD 4
- GENC 0
- Target Price
- AARD $31.50
- GENC N/A
- AVG Volume (30 Days)
- AARD 113.5K
- GENC 37.9K
- Earning Date
- AARD 01-01-0001
- GENC 05-09-2025
- Dividend Yield
- AARD N/A
- GENC N/A
- EPS Growth
- AARD N/A
- GENC 35.02
- EPS
- AARD N/A
- GENC 1.11
- Revenue
- AARD N/A
- GENC $113,116,000.00
- Revenue This Year
- AARD N/A
- GENC N/A
- Revenue Next Year
- AARD N/A
- GENC N/A
- P/E Ratio
- AARD N/A
- GENC $11.54
- Revenue Growth
- AARD N/A
- GENC 5.44
- 52 Week Low
- AARD $7.74
- GENC $11.95
- 52 Week High
- AARD $19.58
- GENC $24.88
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- GENC 42.95
- Support Level
- AARD N/A
- GENC $12.40
- Resistance Level
- AARD N/A
- GENC $13.77
- Average True Range (ATR)
- AARD 0.00
- GENC 0.75
- MACD
- AARD 0.00
- GENC 0.05
- Stochastic Oscillator
- AARD 0.00
- GENC 14.00
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.